AusBiotech is offering a list of optional activities for Tuesday 23 May. You can opt in for one of the options below during the registration process

 

Medical Technology Research Institute Tour*

10:00am - 4:00pm

The Medical Technology Research Institute Tour will explore some of the world’s leading medical research institutes including the Bionics Institute, the St Vincent's Institute of Medical Research and the newly-developed Aikenhead Centre for Medical Discover (ACMD) research facility, BioFab3D@ACMD. Together these institutes provide a unique model for collaboration between researchers, clinicians, end-users and industry in Melbourne’s CBD.

This tour will provide the opportunity to:

  • Visit cutting-edge institutes and centres
  • View research, facilities and capabilities within Melbourne’s CBD
  • Meet academics driving the latest medical technology research

*The tour is not included in the conference registration. You can register for the tour during the registration process for an additional $15

 

Regulatory affairs and health economics workshop

Location: TBC

9:30am - 5:30pm

AusMedtech, the national industry group representing the medical devices and diagnostics industry sector in Australia, invites you to attend the Regulatory Affairs and Health Economics Workshop at AusMedtech 2017 & ICMMB 2017.

While Australia boasts a strong market for developing medical technology, yet the landscape is complex and dynamic. This workshop will explore this landscape, presenting current trends and emerging issues that may affect organisations operating in the medical device industry.

The AusMedtech Regulatory Affairs Expert Panel will lead the morning session, focusing on the Therapeutic Goods Administration (TGA)’s Medicines and Medical Devices Review (MMDR), changes in the European Union (EU) and provide an overview of risk classification.

The afternoon session, led by the Health Economics Expert Panel, will discuss prostheses prices and continuing reform of private health insurance. 

View the full program and register here

 

Phillips Ormonde Fitzpatrick networking event

6:00 - 7:30pm

Enjoy a relaxed evening of networking hosted by Phillips Ormonde Fitzpatrick in their Melbourne's offices 

Express your interest, spaces are limited

9:00 - 9:30am

Arrival and registration for AusMedtech 2017 & ICMMB 2017

9:30 - 10:00am 
Official conference welcome

 

Glenn Cross, AusBiotech, CEO

Yosry Morsi, ICMMB Chair

Host state partner welcome
 
             
                            

10:00 - 11:00am

 

Plenary: The Bionic Eye: Restoring sight with vision prostheses

The bionic eye aims to deliver functional vision and improved quality of life for patients with degenerative vision loss caused by conditions such as retinitis pigmentosa and age-related macular degeneration. This talk will present recent developments and the challenges associated with providing clinically safe and commercially competitive technologies to provide functional everyday benefits to patients. The Bionic Vision Australia research program, which has developed a fully implantable device that is based upon the successful prototype study with three patients, will be outlined.

 

Prof Anthony N Burkitt, Director, Bionic Vision Australia, University of Melbourne 

11:00 - 12:00pm

 

 Plenary: We are such stuff as dreams are made on

The concept of harnessing the power of science and technology to deliver personalised medical solutions for trauma, tumour, degeneration, and disease has become an irresistible quest that has galvanised scientists and clinicians. The rapid advances in technology has enabled scientific discovery, greater innovation and more significant impact of treatments.

 

Prof Peter Choong, Sir Hugh Devine Professor of Surgery, University of Melbourne Director of Orthopaedics, St. Vincent’s Hospital Melbourne

12:00 - 1:00pm

Lunch and networking with exhibitors

‘Meet the AusMedtech Regulatory Affairs Expert Panel’ networking lunch 

 

AusMedtech breakout sessions

ICMMB breakout sessions

1:00 - 2:00pm

Emerging technologies

 

Chair: Warren Bingham, VP Asia Pacific, Clinical Genomics

 

Dr Gil Stynes, Department of Surgery, St. Vincent’s Hospital, University of Melbourne

Jenny O’Neill, CEO and co-founder, Episoft 

Samuel Holt, Founder, Skinview

Regulatory Affairs

Implementation of recommendations from the Review of Medicines and Medical Devices Regulation report

 

A/Prof John Skerritt, Deputy Secretary, Health Products Regulation Group, Department of Health 

Biomaterials and Tissue Engineering - Part 1

 

Keynote speaker: Prof Shengmin Zhang, Huazhong University of Science and Technology

 

Tonghe Zhu, Donghua University, Shangai, China

Braid-Reinforced Nanofibrous Small Diameter Vascular Grafts for Potential Vascular Tissue Reconstruction

 

Prof Simon Moulton, Swinburne University of Technology, Australia

Biofabrication for drug delivery

Advances in Stem Cell Therapies – Part 1

 

Keynote speaker: Prof Samira Musah, Harvard University (USA)

Stem cell-based model of human organ development and function

2:00-3:00pm

Business models for medical technologies

 

Chair: Peter Bradley, VP Global Business Development, LBT Innovations  

 

Phoebe Macleod, Head of Legal and Licensing, Digital Health, MCRI 

 

Nick Haan, Executive Director, OncoDx

Medical device clinical trials: Developments in the Australian landscape

 

Chair: Lorraine Chiroiu, Deputy CEO, AusBiotech

 

Sue MacLeman, CEO & Managing Director, MTPConnect

Measuring the economic value of CTs: MTPConnect's work to support the Industry

 

Lyndon Crossley, Director of Clinical affairs, Global Orthopaedic Technology

The evolving nature of CTs for post-market regulation and reimbursement in light of new technologies

 

Adele Hosseini, Director of Clinical Affairs

The new normal: Case study on CTs in non-typical circumstances

 

Kylie Sproston, Chief Executive, Bellberry Limited

NHMRC National Scientific Committees & their role with clinical trials

 

Dr David Lloyd, Managing Director, Southern Star Research

Future Outlook for CTs in Australia

 

Biomaterials and Tissue Engineering - Part 2

 

Keynote speaker: Prof Yasuhiko Tabata, Kyoto University, Japan

Tissue Engineering of Biomaterials Technology to Realize Regeneration Medicine 

 

Lilith Caballero Aguilar, Swinburne University of Technology, Australia

Preparation and characterization of Polycaprolactone- Alginate microspheres for drug delivery

 

Shaun Gietman, Swinburne University of Technology, Australia

Synthesis of Optically Active Drug Delivery Systems 

Medical, Rehabilitation robotics and Assistive Devices-Part 1

 

Keynote speaker: Prof Romano Zannoli, University of Bologna, Italy

When you need, it never works : incongruence between technological solutions and clinical  needs

 

Dr Boyin Ding, The University of Adelaide, Australia

The impact of 6DOF loading speed on the viscoelastic behaviour of the femur 

3:00 - 3:45pm

Afternoon tea and networking with exhibitors

3:45 - 4:45pm

Overcoming barriers to Global market access

Barriers to overcome to access market:

- Regulatory / Clinical trials

- Re-imbursement

- Distribution

- Cultural barriers

 

Chair: Brendan Mason, Managing Director, Sino-Oz 

 

Frances Pennell-Buck, Inward Investment Specialist - Medical technology sector, UK Department of International Trade

 

Simon Lewi, Director of Regulatory Affairs, ResMed

 

Simranjit Singh, General Manager, Medical Devices & Diagnostics Asia, Quintiles

 

Mike Heyl, Partner, Hogan Lovells

 

 

Is the Company Investable?

IP and Related Issues from Company, Investor and Adviser Perspectives

 

Chair: Rob McInnes, Partner, DibbsBarker

 

Peter Franke, Principal, Franke Hyland

 

Brigitte Smith, Managing Director, GBS Venture Partners

 

Dr Abby Bloom, Executive Chair, Acu Rate Pty Ltd 

 

Electrospinning– Part 1

 

Keynote speaker: Prof Xiumei Mo, Donghau University, China

Electrospun 3D Porous Nanofiber Scaffolds for Ligament and Cartilage Tissue Engineering

 

Riyadh Al-Attabi, Swinburne University of Technology, Australia

The use of electrospun nanofibers membranes for the removal viruses and bacteria from air 

Neuroscience and Neuroengineering - Part 1

 

Keynote speaker: Prof Rikky Muller, University of California, USA

4:45 - 5:45pm

Delivering on the potential of digital health

 

Adam Wardell, Head of Strategy, Innovation and BD&L, Novartis

 

Dr Rob Grenfell, Health Director, CSIRO Health and Biosecurity

 

Challenges in re-imbursement of prostheses

 

Chair: Dominic Tilden, Director, Thema Consulting

 

Medical, Rehabilitation robotics and Assistive Devices - Part 2

 

Keynote speaker: Prof Yosry Morsi, Swinburne University of Technology, Australia 

 

Eric Wu, University of Queensland, Australia

Talking Heart to Heart: Towards an Intelligent Rotary Blood Pump

 

Shih-Yun Lin, National Cheng Kung University, Taiwan

Design and Stiffness Analysis of New Designed Rocker Shoe Soles 

 

Pier Luca Rossi, University of Bologna, Italy

Mechanical and radiological aspects of carbon dioxide coronal angiography: a study of feasibility

 

Ivan Corazza, University of Bologna, Italy

Low Gradient severe aortic stenosis: how is it possible?

 

Biomechanics and Computer modeling/simulation-Part 1

 

Fernando Jativa, University of Melbourne, Australia

Biomechanics and functionality of human lung 3D smooth muscle and fibroblast spheroids 

Biomechanics and Computer modeling/simulation-Part 1

5:45 - 7.00pm

Iverson Health Innovations Research Institute Launch Event - Pre-Dinner Drinks

Supported by:

   

 

7:00 - 10:00pm

AusMedtech Cook Conference Dinner

 

      

 

7:45 - 8:45am

Australian National Fabrication Facility business breakfast

8:30 - 9:00am

Registration desk opens

9:00 - 9:45am

CEOs' session: What keeps you awake at night

 

Chair: Lusia Guthrie, Chairman, Clever Culture Systems

 

Peter Rowland, Managing Partner, Micro-X Ltd

 

Michael Kavanagh, CEO and President, Nanosonics

 

Stuart Elliott, CEO, Planet Innovation

 

Matthew Hoskin, COO, Sienna Cancer Diagnostics 

ICMMB Plenary

 

Keynote speaker: Prof William Wagner, University of Pittsburgh, USA

9:45 - 10:20am

 

BTF panel update on the Biomedical Translation Fund

 

Peter Wills AC, Chair, BTF Committee  

 

Anne-Marie Birkill, General Partner and Executive Director, OneVentures Pty Ltd 

 

Dr Chris Nave, Managing Director, Brandon Capital Partners

 

Dr Amanda Gillon, Investment Manager, BioScience Managers

ICMMB Plenary

 

Keynote speaker: Professor Eiji Matsuura, Okayama University, Japan

Harnessing disease-specific antibody and its variant in “theranostics” of cancer

10:20 - 10:50am

Morning tea

10:50 - 12:00pm

Partnering on Product design and development

 

Biomechanics and Computer modeling/simulation-Part 2

 

Keynote speaker: Prof Fong-Chin Su, National Cheng Kung University, Taiwan 

 

Siamak Nezami Doost, Swinburne University of Technology, Australia

Using computational fluid dynamics to visualize blood flow of a patient-specific left ventricle

Bioprinting and Biofabrication

 

A/Prof Andrea J. O’Connor, The University of Melbourne, Australia

Magnetic Regulation of Forces and Cell Assembly for Tissue Engineering

12:00-1:00pm

Collaboration for commercialisation

 

Chair: Dr Joanne Boag, Senior Manager, Intellectual Property and Commercialisation, MCRI 

 

Samih Nabulsi, General Manager, Cook Australia

 

Bronwyn Le Grice, Co-Founder and CEO, ANDHealth 

 

Charlie Day, CEO, Office of Innovation and Science Australia

What is Goverment's Policy on medtech

 

Chair: Lorraine Chiroiu, Deputy CEO, AusBiotech

 

Andrew Wear, Director, Medical Technologies and Pharmaceuticals Department of Economic Development, Jobs, Transport and Resources 

 

Marco Baccanti, Chief Executive, Health Industries South Australia

Biomechanics and Computer modeling/simulation-Part 3

 

Keynote speaker: Prof Itsu Sen (Yi Qian), Macquarie University, Australia

Advances in stem cell therapies - Part 2

 

Keynote speaker: Prof Paul Verma, Monash Institute of Medical Research, Australia

1:00 - 2:00pm

Lunch

2:00 - 2:45pm

Risk process for Medical device Development and Commercialisation

Benefits of following a risk driven process followed by a panel case study

 

Keynote speaker: Toby McSweeney, Head of Class III Development Group, Hydrix

 

Panel:

 

Chair: Toby McSweeney, Head of Class III Development Group, Hydrix

 

Liza Dunne, CEO, OncoRes 

 

Kath Giles, Investment Manager, Brandon Capital

 

ICMMB Plenary

 

Keynote speaker: Prof Anthony Weiss, University of Sydney, Australia

2:45 - 3:25pm

Update on the Federal Government Growth Centre

 

Sue MacLeman, Managing Director and CEO, MTPConnect

 

Michael Grogan, Victorian Director, Advanced Manufacturing Growth Centre 

 

Advances in medical devices - Design and optimisation

 

Keynote speaker: Dr Dan Abrams, Cerebral Therapeutics 

Creating Value in Central Nervous System startups

 

Biomaterials

 

Paul R. Stoddart, Swimburne University of Technology, Australia

Dynamic Mechanical Properties of PDMS Measured on the Mesoscale with an Optical Fibre Sensor

 

Daniela Duc, Swinburne University of Technology, Australia

Fabrication of Gold Nanorod conjugated Reduced Graphene Oxide for Optical and Electrical Cell Co-Stimulation 

 

Xian Wen Tan, Okayama University, Japan

Natural Ameliorative Biomaterial for Oxidative Stress and Inflammation 

 

3:25 - 4:45pm

Frost & Sullivan 

Report on the Medtech sector

3:45 - 4:15pm

Afternoon tea

4:15 - 5:15pm

On the couch ICMMB & AusMedtech wrap-up session 

5:15 - 6:15pm

Closing Drinks

supported by: